The link between oxytocin and MDMA is less straightforward than once thought.
Exploring the historical, traditional, and entheogenic contexts of ayahuasca for further understanding of its therapeutic value.
Receptor testing of the affinity and potency of compounds is a critical component of psychedelic research.
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
“…this stands up to scientific rigor and is worthy of further exploration.”
This company is approaching psychedelic mushroom research literally from the ground up.
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.